57 related articles for article (PubMed ID: 1622141)
21. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
22. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.
Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H
Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200
[TBL] [Abstract][Full Text] [Related]
23. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
Danilenko M; Wang Q; Wang X; Levy J; Sharoni Y; Studzinski GP
Cancer Res; 2003 Mar; 63(6):1325-32. PubMed ID: 12649194
[TBL] [Abstract][Full Text] [Related]
24. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
25. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
Yen A; Sturgill R; Varvayanis S; Chern R
Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255
[TBL] [Abstract][Full Text] [Related]
26. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
[TBL] [Abstract][Full Text] [Related]
27. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
Sokoloski JA; Shyam K; Sartorelli AC
Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human interleukin-6 enhances the antiproliferation and differentiation inducing effects of retinoic acid in HL-60 human myeloid leukaemic cells.
Hassan HT
Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):847-51. PubMed ID: 1797449
[TBL] [Abstract][Full Text] [Related]
29. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
Hassan HT; Veit A; Maurer HR
J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642
[TBL] [Abstract][Full Text] [Related]
30. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate.
Atkins KB; Troen BR
Blood; 1995 Oct; 86(7):2475-80. PubMed ID: 7670094
[TBL] [Abstract][Full Text] [Related]
31. Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells.
Doré BT; Uskokovìc MR; Momparler RL
Leuk Res; 1993 Sep; 17(9):749-57. PubMed ID: 8396695
[TBL] [Abstract][Full Text] [Related]
32. Clonal analysis of the response of HL-60 cells to retinoic acid and vitamin D in the presence or absence of leukocyte-conditioned medium.
Soppi E; Robért KH; Gahrton G
Eur J Haematol; 1988 Jul; 41(1):66-73. PubMed ID: 3402589
[TBL] [Abstract][Full Text] [Related]
33. The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids.
Glorieux G; Hsu C; De Smet R; Dhondt A; van Emmelo J; Waterloos MA; Lameire N; Plum J; Vanholder R
Nephrol Dial Transplant; 2001 Feb; 16(2):246-52. PubMed ID: 11158396
[TBL] [Abstract][Full Text] [Related]
34. Effects of vitamin D and retinoic acid on human glioblastoma cell lines.
Magrassi L; Butti G; Pezzotta S; Infuso L; Milanesi G
Acta Neurochir (Wien); 1995; 133(3-4):184-90. PubMed ID: 8748764
[TBL] [Abstract][Full Text] [Related]
35. Novel vitamin D analogues; cytotoxic and anti-proliferative activity against a diffuse large B-cell lymphoma cell line and B-cells from healthy donors.
Kozielewicz P; Grafton G; Kutner A; Curnow SJ; Gordon J; Barnes NM
J Steroid Biochem Mol Biol; 2016 Nov; 164():98-105. PubMed ID: 26485664
[TBL] [Abstract][Full Text] [Related]
36. Abolition of L1210 clonogeneticy and G1 arrest by retinoic acid and 1,25-dihydroxyvitamin D3.
Moqattash S; Lutton JD; Chiao JW; Levere RD
Cancer Lett; 1985 Jun; 27(2):125-34. PubMed ID: 3839165
[TBL] [Abstract][Full Text] [Related]
37. Prevention of S-D-lactoylglutathione-induced inhibition of human leukaemia 60 cell growth by uridine.
Edwards LG; Thornalley PJ
Leuk Res; 1994 Sep; 18(9):717-22. PubMed ID: 7934147
[TBL] [Abstract][Full Text] [Related]
38. Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues.
Moore MA; Gabrilove J; Sheridan AP
Haematol Blood Transfus; 1983; 28():327-37. PubMed ID: 6574954
[No Abstract] [Full Text] [Related]
39. [1 alpha 25-dihydroxyvitamin D3 (calcitriol) and malignant hemopathies. Decreased serum levels in acute leukemia: preliminary results].
Guerci A; De Talance N; Witz F; Kohler F; Guerci O; Burlet C; Lederlin P
Rev Med Interne; 1989; 10(5):405-8. PubMed ID: 2488481
[TBL] [Abstract][Full Text] [Related]
40. Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation.
Boto C; Quartin E; Cai Y; Martín-Lorenzo A; Cenador MBG; Pinto S; Gupta R; Enver T; Sánchez-García I; Hong D; Pires das Neves R; Ferreira L
Nat Commun; 2017 May; 8():15204. PubMed ID: 28492285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
